Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
3.800
-0.170 (-4.28%)
At close: Jun 18, 2026, 4:00 PM EDT
3.700
-0.100 (-2.63%)
After-hours: Jun 18, 2026, 7:55 PM EDT
Quantum BioPharma Market Cap
Quantum BioPharma has a market cap or net worth of $24.37 million as of June 18, 2026. Its market cap has decreased by -38.14% in one year.
Market Cap
24.37M
Enterprise Value
18.75M
1-Year Change
-38.14%
Ranking
Category
Stock Price
$3.80
Market Cap Chart
Since January 9, 2020, Quantum BioPharma's market cap has decreased from $53.50M to $24.37M, a decrease of -54.44%. That is a compound annual growth rate of -11.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 14.80M | -46.95% |
| Dec 31, 2025 | 27.90M | 304.35% |
| Dec 31, 2024 | 6.90M | -80.94% |
| Dec 29, 2023 | 36.20M | 20.67% |
| Dec 30, 2022 | 30.00M | -27.18% |
| Dec 31, 2021 | 41.20M | 108.08% |
| Dec 31, 2020 | 19.80M | -62.99% |
| Jan 9, 2020 | 53.50M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Longeveron | 25.54M |
| Evaxion | 25.44M |
| BriaCell Therapeutics | 25.30M |
| Polyrizon | 25.12M |
| Skye Bioscience | 24.85M |
| Tvardi Therapeutics | 24.67M |
| Faeth Therapeutics | 23.91M |
| Neuphoria Therapeutics | 23.29M |